By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CEL-SCI Corporation 

8229 Boone Boulevard
Suite 802
Vienna  Virginia  22182  U.S.A.
Phone: 703-506-9460 Fax: 703-506-9471


SEARCH JOBS








Company News
CEL-SCI (CVM) Enrolls 22 Patients During October In Its Phase 3 Immunotherapy Head And Neck Cancer Trial 11/3/2014 10:39:15 AM
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $6 Million 10/24/2014 10:54:31 AM
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock And Warrants 10/21/2014 1:01:17 PM
Coverage Initiation Report Focuses On CEL-SCI (CVM) 10/3/2014 11:50:38 AM
CEL-SCI (CVM) Enrolls 16 Patients In September In Its Phase 3 Immunotherapy Head And Neck Cancer Trial 10/3/2014 7:38:31 AM
CEL-SCI (CVM) & U.S. Navy Administer Multikine To First Volunteer Patient In Phase I Clinical Trial For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients 9/29/2014 1:27:48 PM
University of Minnesota Masonic Cancer Center Joins CEL-SCI (CVM)’s Phase 3 Head & Neck Cancer Trial 9/10/2014 10:25:22 AM
CEL-SCI (CVM) Enrolls 20 Patients In August In Its Phase 3 Immunotherapy Head And Neck Cancer Trial 9/3/2014 9:09:02 AM
CEL-SCI (CVM) Expands Its Global Phase 3 Immunotherapy Head And Neck Cancer Trial Into Centre Hospitalier Universitaire De Quebec In Canada 8/19/2014 8:52:45 AM
CEL-SCI (CVM) Reports Third Quarter Fiscal 2014 Financial Results 8/11/2014 8:48:09 AM
12345678910...
//-->